634
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: The importance of compound lipophilicity

, &
Pages 1-6 | Received 24 Feb 2006, Accepted 17 Jul 2006, Published online: 20 Oct 2008

References

  • Lewis DFV. Cytochromes P450: Structure, function and mechanism. Taylor & Francis, London 1996
  • Lewis DFV. Guide to cytochromes P450 structure and function. Taylor & Francis, London 2001
  • Cytochrome P450. PR Ortiz de Montellano. Plenum, New York 1995
  • Cytochrome P450. PR Ortiz de Montellano. Kluwer/Plenum, New York 2005
  • Lewis DFV. 57 Varieties: the human cytochromes P450. Pharmacogeneomics 2004; 5: 305–318
  • Lewis DFV. Quantitative structure-activity relationships (QSARs) within human cytochrome P450 substrates of he CYP2 family. Toxicol in vitro 2004; 18: 89–97
  • Lewis DFV, Wiseman A, Tarbit MH. Molecular modelling of lanosterol 14α-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: Quantitative structure-activity relationships (QSARs) within a number of antifungal agents. J Enz Inhib 1999; 14: 175–192
  • Lewis DFV, Lake BG, Dickins M, Ueng Y-F, Goldfarb PS. Homology modelling of human CYP1A2 based on the CYP2C5 crystallographic template structure Xenobiotica. 2003; 33: 239–254
  • Lewis DFV, Gillam EMJ, Everett SA, Shimada T. Molecular modelling of human CYP1B1 substrate interactions and investigation of allelic variant effects on metabolism. Chem-Biol Inter 2003; 145: 281–295
  • Lewis DFV, Lake BG, Dickins M, Goldfarb PS. Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: Enzyme-substrate interactions. Toxicol in vitro 2003; 17: 179–190
  • Lewis DFV, Lake BG, Dickins M. Quantitative structure-activity relationships (QSARs) in CYP3A4 inhibitors: The importance of lipophilic character and hydrogen bonding. J Enz Inhib Med Chem 2006; 21: 127–132
  • Lewis DFV, Jacobs MN, Dickins M. The importance of compound lipophilicity for substrate binding to human P450s involved in drug metabolism. Drug Disc Today 2004; 9: 530–537
  • Hosea NA, Miller GP, Guengerich FP. Elucidation of distinct ligand binding sites for cytochrome P450 3A4. Biochemistry 2000; 39: 5929–5939
  • Kenworthy KE, Clarke SE, Andrews J, Houston JB. Multisite kinetic models for CYP3A4: Simultaneous activation and inhibition of diazepam and testosterone metabolism. Drug Metab Disp 2001; 29: 1644–1651
  • Lewis DFV, Wiseman A. A selective review of bacterial forms of cytochrome P450 enzymes. Enz Microbial Technol 2005; 36: 377–384

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.